ClinicalTrials.gov term: Primary Myelofibrosis

Disease landscape

Myelofibrosis clinical trials

Get alerts when Myelofibrosis trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

12 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 10 with minor changes only.

  1. Notable

    Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

    Primary completion pushed from Sep 2026 to Sep 2027

    Also in this update: Study completion pushed from Mar 2027 to Mar 2028

    Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsEarly Phase 1 NCT06398457 Registry history of NCT06398457 on ClinicalTrials.gov (opens the registry)

Show 10 trials with minor changes only
  1. Minor

    LY5830966 · Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)

    Start date moved earlier from Oct 23, 2024 to Oct 3, 2024

    Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli Lilly and CompanyPhase 1 NCT06343805 Registry history of NCT06343805 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

New sponsor entrants, last 90 days sponsors with their first trial in this area

First postedTrialSponsorPhase
2026-10-07 NCT07863466 MPNdpoint. Single-center, Retrospective, Prospective Study of the Outcome of Patients… Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico new

Active trials by phase

Early Phase 1
3
Phase 1
41
Phase 1/2
16
Phase 2
42
Phase 2/3
1
Phase 3
13
Phase 4
2
Not charted: 40 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Top sponsors by active trials in this area

Get alerts when Myelofibrosis trials change
Status changes, date slips, and new sponsor entrants: detected daily, delivered to your inbox.
Start monitoring free